id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-D-4750-0012,FDA,FDA-2015-D-4750,"Attachment 1 Draft Guidance "" Implementation of the
''Deemed to be a License'' Provision of the Biologics Price Competition and Innovation Act of 2009"" re: Comment from Biotechnology Innovation Organization",Supporting & Related Material,Background Material,2016-06-07T04:00:00Z,2016,6,,,2016-06-07T14:02:24Z,,0,0,0900006482018d24
FDA-2015-D-4750-0001,FDA,FDA-2015-D-4750,Implementation of the ‘‘Deemed To Be a License’’ Provision of the Biologics Price Competition and Innovation Act of 2009; Draft Guidance for Industry; Availability and Request for Comments,Notice,Notice of Availability,2016-03-14T04:00:00Z,2016,3,2016-03-14T04:00:00Z,2016-05-14T03:59:59Z,2016-05-14T04:00:39Z,2016-05626,0,0,0900006481ebf885
FDA-2015-D-4750-0002,FDA,FDA-2015-D-4750,Draft Guidance for Industry: Implementation of the “Deemed to be a License” Provision of the Biologics Price Competition and Innovation Act of 2009,Other,Guidance,2016-03-14T04:00:00Z,2016,3,2016-03-14T04:00:00Z,,2024-11-12T05:56:21Z,,1,0,0900006481ebffbd